Search
for
Sort by
Research 151–180 of 1000+
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia
- Gynécomastie et finastéride (Propecia®) : 4 nouveaux cas
- Post-finasteride syndrome – does it really exist?
- Exploring rat corpus cavernosum alterations induced by finasteride treatment and withdrawal
- The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis
- Sindrome post-finasteride: tra mito e realtà
- Sexuality and old age
- Post-finasteride syndrome: An emerging clinical problem
- The pathophysiology of delayed ejaculation
- Nonsurgical Therapy for Hair Loss
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Long-term consequences of critical illness
- Hormesis and medicine
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Treatment options for alopecia: an update, looking to the future
- Menopause in Women, Andropause in Men: Myth, Reality, and Management
- Oral Minoxidil Therapy in Hair Loss: Where Do We Stand?
- Case 21-2012
- Aldesleukin
- A comment on the post-finasteride syndrome
- Using 5 alpha reductase inhibitors safely: What primary care physicians need to know
- The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review
- Outcome domains in lichen sclerosus
- Commonly encountered symptoms and their management in patients with cirrhosis
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- Ejaculations and Benign Prostatic Hyperplasia: An Impossible Compromise? A Comprehensive Review
- Self-assembling peptide inspired by insulin and type 1 insulin-like growth factor for the treatment of androgenetic alopecia
- Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database